Medicine and Dentistry
Stent
100%
Patient
83%
Rapamycin
69%
Percutaneous Coronary Intervention
66%
Inpatient
63%
Umirolimus
53%
Polymer
46%
Zotarolimus
30%
Therapeutic Procedure
30%
Noninferiority Trial
25%
ST Segment Elevation Myocardial Infarction
23%
Everolimus
23%
Target Lesion
22%
Diabetes
21%
Lesion
21%
Follow up
21%
Primary Percutaneous Coronary Intervention
20%
Diabetes Mellitus
18%
Revascularization
17%
Randomized Controlled Trial
15%
Acute Heart Infarction
15%
Drug-Eluting Stent
15%
Analysis
11%
Myocardial Infarction
10%
Cardiovascular System
9%
Amaurosis
9%
Target Lesion Revascularization
9%
Association
9%
Intention-to-Treat Analysis
8%
Acute Coronary Syndrome
8%
Diseases
8%
Randomized Clinical Trial
7%
Conditioning
7%
Intravascular Ultrasound
7%
Artery Intima Proliferation
7%
Indicator
7%
Angiography
7%
Coronary Occlusion
7%
Chronic Total Occlusion
7%
Cardiology
7%
Hospital
7%
Fibrinolysis
6%
Stent Thrombosis
6%
Patient with Diabetes
6%
Heart Death
6%
Artery
5%
Hazard Ratio
5%